{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:20:07Z","timestamp":1740460807431,"version":"3.37.3"},"reference-count":20,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1183\/13993003.02026-2023","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T09:35:26Z","timestamp":1701941726000},"page":"2302026","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cast no shadow: assessing the disease-modifying effects of elexacaftor\/tezacaftor\/ivacaftor"],"prefix":"10.1183","volume":"62","author":[{"given":"Peter J.","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-9828","authenticated-orcid":false,"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2024102012400098000_62.6.2302026.1","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"key":"2024102012400098000_62.6.2302026.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2024102012400098000_62.6.2302026.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2024102012400098000_62.6.2302026.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102012400098000_62.6.2302026.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0392OC"},{"key":"2024102012400098000_62.6.2302026.6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.202301-0084OC","article-title":"Phase 3 open-label clinical trial of elexacaftor\/tezacaftor\/ivacaftor in children aged 2\u20135 years with cystic fibrosis and at least one F508del allele","volume":"208","author":"Goralski","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012400098000_62.6.2302026.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02029-2022"},{"key":"2024102012400098000_62.6.2302026.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201503-0578OC"},{"key":"2024102012400098000_62.6.2302026.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200502-273OC"},{"key":"2024102012400098000_62.6.2302026.10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jcf.2023.03.002","article-title":"Real-world safety and effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: interim results of a long-term registry-based study","volume":"22","author":"Bower","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2024102012400098000_62.6.2302026.11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012400098000_62.6.2302026.12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215556"},{"key":"2024102012400098000_62.6.2302026.13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcf.2022.05.005","article-title":"Research letter: the impact of elexacaftor\/tezacaftor\/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis","volume":"21","author":"Song","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102012400098000_62.6.2302026.14","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00588-2021"},{"key":"2024102012400098000_62.6.2302026.15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcf.2022.01.012","article-title":"Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis","volume":"21","author":"Martin","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102012400098000_62.6.2302026.16","first-page":"e167957","article-title":"Lung function trajectories and associated mortality among adults with and without airway obstruction","volume":"133","author":"Backman","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102012400098000_62.6.2302026.17","doi-asserted-by":"crossref","first-page":"e167957","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J Clin Invest"},{"key":"2024102012400098000_62.6.2302026.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02153-2022"},{"key":"2024102012400098000_62.6.2302026.19","doi-asserted-by":"crossref","unstructured":"Ramsey B , Correll CU , DeMaso DR , et al. Elexacaftor\/tezacaftor\/ivacaftor treatment and depression-related events. Am J Respir Crit Care Med 2023; in press [https:\/\/doi.org\/10.1164\/rccm.202308-1525OC]. doi:10.1164\/rccm.202308-1525OC","DOI":"10.1164\/rccm.202308-1525OC"},{"key":"2024102012400098000_62.6.2302026.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02437-2022"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02026-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:38:24Z","timestamp":1740382704000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02026-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1183\/13993003.02026-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02026-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}